Increasing Use Of Interferon Gamma Release Assays Among Children ≥2 Years of Age in a Setting With Low Tuberculosis Prevalence.
Jeffrey I CampbellMary TabatneckMingwei SunWei HeNicholas MusinguziBethany Hedt-GauthierGabriella S LambDon GoldmannVishakha SabharwalThomas J SandoraJessica E HabererPublished in: The Pediatric infectious disease journal (2022)
US guidelines recommend interferon gamma release assays (IGRAs) for diagnosis of tuberculosis infection in children. In this retrospective cohort study, IGRA use in children 2-17 years of age increased substantially between 2015 and 2021. Testing in inpatient/subspecialty settings (vs. primary care), public (vs. private) insurance, lower age and non-English preferred language were associated with increased odds of receiving an IGRA.